Brief: Palisade Bio Receives Canadian Patent Covering Composition Of Lead Program In Development, LB1148
06/04/2023 14:11
April 6 (Reuters) - Palisade Bio Inc PALI.O :
* PALISADE BIO RECEIVES CANADIAN PATENT COVERING COMPOSITION
OF
LEAD PROGRAM IN DEVELOPMENT, LB1148
* PALISADE BIO INC - EXPECTS TO REPORT TOPLINE DATA FROM 35
PATIENTS ENROLLED IN STUDY IN Q2 OF 2023
Source text for Eikon: ID:nGNX7tsGkL
Further company coverage: PALI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Palisade Bio
See all newsPalisade Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Palisade Bio Q2 net loss widens on higher R&D costs
Brief: Palisade Bio Q2 EPS USD -0.05
Palisade Bio Inc expected to post a loss of 5 cents a share - Earnings Preview
Brief: Palisade Bio Inc - May Offer And Sell Up To $300 Million Of Securities - SEC Filing